Concepedia

Matthew B. Cohen

MB

Statistics

Publications

6

Citations

293

H-Index

6

Active since

1985

Affiliations

Beth Israel Deaconess Medical Center(Current)

Matthew B. Cohen is an author at Beth Israel Deaconess Medical Center specializing in pharmacology, cancer pharmacology, and medicine.

Publications per year

1985–2013

6

Publications

6

The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma

Daniel C. Cho, Matthew B. Cohen, David J. Panka et al. · Clinical Cancer Research · 2010 · 191 citations · Full text

, , +17

Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.

Matthew B. Cohen, Robert I. Glazer · Molecular Pharmacology · 1985 · 33 citations

, , +17

Treatment of Post–Electroconvulsive Therapy Agitation With Dexmedetomidine

Matthew B. Cohen, Jonathan T. Stewart · Journal of Ect · 2013 · 23 citations

, , +13

PI3K inhibition potentiates Bcl‐2‐dependent apoptosis in renal carcinoma cells

Shudong Zhu, Matthew B. Cohen, Jeffrey D. Bjorge et al. · Journal of Cellular and Molecular Medicine · 2013 · 18 citations · Full text

, , +17

Comparison of the cellular and RNA-dependent effects of sangivamycin and toyocamycin in human colon carcinoma cells.

Matthew B. Cohen, Robert I. Glazer · Molecular Pharmacology · 1985 · 15 citations

, , +11

1–5 of 6